These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9464576)

  • 21. Inotropic agents in older patients with chronic heart failure--current perspectives.
    Carbonin PU; Zuccalà G
    Aging (Milano); 1996 Apr; 8(2):90-8. PubMed ID: 8737606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inotropic agents and immune modulation.
    Sasayama S
    Cardiovasc Drugs Ther; 2002 May; 16(3):237-43. PubMed ID: 12374902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation: a new horizon for medical treatment of heart failure.
    Sasayama S; Matsumori A; Matoba Y; Matsui S; Yamada T; Shioi T; Sato Y; Doyama K; Kishimoto C
    J Card Fail; 1996 Dec; 2(4 Suppl):S287-94. PubMed ID: 8951591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-gamma-stimulated cultured vascular smooth muscle cells.
    Chou TC; Yang SP; Pei D
    Jpn J Pharmacol; 2002 Jun; 89(2):157-63. PubMed ID: 12120758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesnarinone: a new inotropic agent for treating congestive heart failure.
    Cavusoglu E; Frishman WH; Klapholz M
    J Card Fail; 1995 Jun; 1(3):249-57. PubMed ID: 9420657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 28. Vesnarinone: a potential cytokine inhibitor.
    Sasayama S; Matsumori A
    J Card Fail; 1996 Sep; 2(3):251-8. PubMed ID: 8891863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New positive inotropic agents.
    Jafri SM; Bristol JA
    Henry Ford Hosp Med J; 1986; 34(3):188-92. PubMed ID: 3542907
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
    Deswal A; Petersen NJ; Feldman AM; Young JB; White BG; Mann DL
    Circulation; 2001 Apr; 103(16):2055-9. PubMed ID: 11319194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure.
    Matsumori A; Sasayama S
    Heart Fail Rev; 2001 Mar; 6(2):129-36. PubMed ID: 11309531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
    Li YC; Luo Q; Ge LS; Chen YH; Zhou ND; Zhang T; Guan XQ; Lin JF
    Biochem Biophys Res Commun; 2013 Feb; 431(3):450-5. PubMed ID: 23333383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phosphodiesterase inhibition as a new positive-inotropic principle].
    Hartmann A; Saeed M; Sütsch G; Bing RJ
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1971-7. PubMed ID: 3539571
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute heart failure: inotropic agents and their clinical uses.
    Endoh M; Hori M
    Expert Opin Pharmacother; 2006 Nov; 7(16):2179-202. PubMed ID: 17059376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines in myocarditis and cardiomyopathies.
    Matsumori A
    Curr Opin Cardiol; 1996 May; 11(3):302-9. PubMed ID: 8835873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.